Stevanato Group to Present at Upcoming Investor Conferences
29 Agosto 2024 - 3:30PM
Business Wire
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider
of drug containment, drug delivery, and diagnostic solutions to the
pharmaceutical, biotechnology, and life sciences industries,
announced today that it will participate in two upcoming investor
conferences.
The Company will present at the Morgan Stanley Healthcare
Conference in New York on Friday, September 6, 2024 at 7:00 a.m.
(ET), and at the Bank of America Global Healthcare Conference in
London on Wednesday, September 18, 2024 at 2:10 p.m. (BST). A live
webcast of each event will be available on the Company’s website at
www.stevanatogroup.com under the "Investors" section. Replays of
the webcasts will be available for approximately 90 days after each
event.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of
drug containment, drug delivery and diagnostic solutions to the
pharmaceutical, biotechnology and life sciences industries. The
Group delivers an integrated, end-to-end portfolio of products,
processes and services that address customer needs across the
entire drug life cycle at each of the development, clinical and
commercial stages. Stevanato Group’s core capabilities in
scientific research and development, its commitment to technical
innovation and its engineering excellence are central to its
ability to offer value added solutions to clients.
For more information, please visit www.stevanatogroup.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240829649352/en/
Media Stevanato Group media@stevanatogroup.com
Investor Relations Lisa Miles
lisa.miles@stevanatogroup.com
Stevanato (NYSE:STVN)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Stevanato (NYSE:STVN)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024